2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes

Submitted by onc_editor on Mon, 01/22/2018 - 15:32

Key Insights

2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes

Advances in both preclinical science and clinical management practices continue to change how MPN and MDS are diagnosed and treated. The 2017 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 4-5, 2017 in Philadelphia, provided a platform for exploring many of the clinical challenges related to the diagnosis and treatment of MPN and MDS. In this activity, the Congress co-chairs highlight the key points presented during the meeting, with the aim of sharing updates that will help you enhance your clinical practice.